Incidence and clinical phenotype of multisystem inflammatory syndrome in children after infection with the SARS-CoV-2 delta variant by vaccination status: a Danish nationwide prospective cohort study예방 접종 상태에 따른 SARS-CoV-2 델타 변이체 감염 후 소아에서 다기관 염증 증후군의 발병률 및 임상 표현형: 덴마크 전국 전향 코호트 연구Article Published on 2022-07-012022-09-11 Journal: The Lancet. Child & adolescent health [Category] COVID19(2023년), SARS, 변종, 임상, [키워드] 95% CI B.1.617.2 Breakthrough infection calculated center children clinical phenotype Cohort cohort study comparable contribute Control COVID-19 Data collection delta variant Delta wave Denmark disease disease control education Effectiveness Factors higher education hospitalised incidence individual infected individuals Infection infection with SARS-CoV-2 Inflammatory Innovation MIS-C number of infected occur pandemic Patient phenotype Poisson regression population-based cohort prevention prospective cohort study rate ratio Registered Research SARS-COV-2 infection SARS-CoV-2 infections SARS-CoV-2 variant Science Surveillance syndrome the SARS-CoV-2 vaccinated individual vaccination Vaccination Status Vaccine variant variant of SARS-CoV-2 was obtained [DOI] 10.1016/S2352-4642(22)00100-6 PMC 바로가기 [Article Type] Article
Clinical efficacy of different monoclonal antibody regimens among non-hospitalised patients with mild to moderate COVID-19 at high risk for disease progression: a prospective cohort study질병 진행 위험이 높은 경증에서 중등도 COVID-19 환자를 대상으로 한 다양한 단일 클론 항체 요법의 임상 효능: 전향적 코호트 연구Observational Study Published on 2022-07-012022-09-11 Journal: European Journal of Clinical Microbiology & Infect [Category] COVID19(2023년), SARS, 변종, 임상, 진단, 치료기술, [키워드] (alpha 95% CI 95% confidence interval adjusted odds ratio analysed anti-SARS-CoV-2 antibody treatment B.1.1.7 bamlanivimab Bamlanivimab-etesevimab, casirivimab-imdevimab baseline Baseline serology Casirivimab circulating variants clinical Clinical outcome clinical outcomes combination regimen conducted COVID-19 COVID-19 outpatient COVID-19 outpatients COVID-19 progression disease Efficacy eight etesevimab Factor groups high risk high-risk population hospital hospitalisation hospitalised Imdevimab Italian Logistic regression mAb Medicine Mild Mild-to-moderate Mild-to-moderate COVID-19 outpatients Moderate COVID-19 monoclonal antibodies monoclonal antibody Monoclonal antibody treatments Monoclonal antibody treatments for COVID-19 multivariable no significant difference no significant differences non-hospitalised Outpatient Patient patient subgroup patients progression proportion prospective cohort study Prospective Study Randomised trial randomised trials receiving regimen SARS-CoV-2 SARS-CoV-2 early treatments. SARS-CoV-2 vaccination SARS-CoV-2 variant serology significant differences significantly higher significantly lower The B.1.1.7 treated vaccination variant [DOI] 10.1007/s10096-022-04464-x PMC 바로가기 [Article Type] Observational Study
A telerehabilitation programme in post-discharge COVID-19 patients (TERECO): a randomised controlled trialRandomized Controlled Trial Published on 2022-07-012022-10-05 Journal: Thorax [Category] 임상, [키워드] 1:1 95% CI aerobic Block randomisation China COVID-19 COVID-19 patient demonstrated Dyspnoea Effect Exercise capacity Follow-up form greater hospital hospitalised increase Jiangsu lower limb muscle Lung function maximum voluntary ventilation outcome physical Pulmonary function pulmonary rehabilitation Quality of life randomised randomised controlled trial rehabilitation secondary survivor Thoracic treatment effect Trial walking distance were assessed [DOI] 10.1136/thoraxjnl-2021-217382 PMC 바로가기 [Article Type] Randomized Controlled Trial
Blood supply, transfusion demand and mortality in Italian patients hospitalised during nine months of COVID-19 pandemicObservational Study Published on 2022-07-012022-10-04 Journal: Blood transfusion = Trasfusione del sangue [Category] 임상, [키워드] Apulia Blood blood component blood donation blood supply Care Clinical outcome COVID patient COVID-19 pandemic COVID-19 patient COVID-19 patients eight fatality Fatality rate hospital hospitalised hospitalised patient ICUs implementation intensive care unit internal Italian patient Kaplan-Meier analysis maintain material Medicine men Mortality nine pandemic Patient performed present proportion RBC red blood cell reduction in Research retrospective significantly higher significantly lower transfused university [DOI] 10.2450/2021.0173-21 PMC 바로가기 [Article Type] Observational Study
Factors associated with clinical progression to severe COVID-19 in people with cystic fibrosis: A global observational studyObservational Study Published on 2022-07-012022-10-05 Journal: Journal of cystic fibrosis : official journal of t [Category] COVID19(2023년), SARS, 유전자 메커니즘, 임상, [키워드] 95%CI acute SARS-CoV-2 infection Analysis AOR body mass index CFTR Clinical characteristics Cohort coronavirus country COVID-19 Cystic cystic fibrosis demographics diabetes effective Factor fibrosis hospital hospitalisation hospitalised increase in International Logistic regression Older age outcome outcomes oxygen Patient prescription Primary outcome progression protective effect recipients reduced reported risk SARS-CoV-2 SARS-COV-2 infection severe COVID-19 Severe infection significantly solid-organ transplant supplemental oxygen Supplemental oxygen therapy symptomatic therapy Transplant Vaccine was used [DOI] 10.1016/j.jcf.2022.06.006 PMC 바로가기 [Article Type] Observational Study
Development of a Mortality Prediction Model in Hospitalised SARS-CoV-2 Positive Patients Based on Routine Kidney Biomarkers일상적인 신장 바이오마커를 기반으로 입원한 SARS-CoV-2 양성 환자의 사망률 예측 모델 개발Article Published on 2022-06-302022-09-11 Journal: International Journal of Molecular Sciences [Category] COVID19(2023년), MERS, SARS, 바이오마커, [키워드] Acute kidney injury acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 age AKI an area analysed AUROC Biomarker Blood blood test blood tests characteristic Cohort coronavirus COVID-19 creatinine develop development Ethnicity focus foundation hospital hospitalised Humber in-hospital mortality increased mortality Inpatients kidney Kidney function kidney function test Kidney function tests Kidney injury Logistic regression logistic regression model main outcome measure Model Mortality National Health Service NHS outcome Patient patients without AKI PCR test positive positive RT-PCR prediction Prediction model predictor prevalent random Random forest receiver operating characteristic regions respiratory resulting retrospective cohort study routine RT-PCR test SARS-CoV-2 SARS-CoV-2 infected patients SARS-CoV-2 positive patient SARS-CoV-2 positive patients severe acute respiratory syndrome Coronavirus Sex sodium test dataset Trust United Kingdom urea [DOI] 10.3390/ijms23137260 PMC 바로가기 [Article Type] Article
Author Correction: An open label randomized clinical trial of Indomethacin for mild and moderate hospitalised Covid-19 patients Amendments and Corrections Published on 2022-06-202022-10-05 Journal: Scientific Reports [Category] 임상, 진단, [키워드] hospitalised indomethacin Mild moderate open label Patient randomized clinical trial [DOI] 10.1038/s41598-022-15107-8 [Article Type] Amendments and Corrections
The contribution of hospital-acquired infections to the COVID-19 epidemic in England in the first half of 20202020년 상반기 영국의 COVID-19 전염병에 대한 병원 획득 감염의 기여도Article Published on 2022-06-182022-09-11 Journal: BMC Infectious Diseases [Category] COVID19(2023년), SARS, 치료기술, [키워드] Admission caused community transmission COVID-19 COVID-19 cases COVID-19 epidemic COVID-19 patient dataset determine discharge distribution England English First wave hospital Hospital-acquired infection hospital-acquired infections hospitalised hospitalised COVID-19 patient hospitalised COVID-19 patients hospitalised patient Hospitalised patients Incubation period individual Infection Inpatient Inpatients less Mathematical modelling measure National Nosocomial transmission Patient proportion recorded resulting SARS-CoV-2 SARS-COV-2 infection symptom onset symptomatic symptomatic SARS-CoV-2 infection the epidemic Transmission Trust [DOI] 10.1186/s12879-022-07490-4 PMC 바로가기 [Article Type] Article
Investigating COVID-19 Vaccine Impact on the Risk of Hospitalisation through the Analysis of National Surveillance Data Collected in Belgium벨기에에서 수집된 국가 감시 데이터 분석을 통한 코로나19 백신이 입원 위험에 미치는 영향 조사Article Published on 2022-06-162022-09-11 Journal: Viruses [Category] COVID19(2023년), SARS, 변종, [키워드] absence Administered age analysed Belgium booster vaccination category Comorbidities COVID-19 COVID-19 hospitalisation COVID-19 patient dominance Evolution Factor hospitalisation hospitalisation surveillance hospitalised Impact infections National omicron Omicron variant Probability receive risk risk of COVID-19 risk ratio risk ratios SARS-CoV-2 SARS-COV-2 infection stratified surveillance data vaccination Vaccination impact Vaccination Status Vaccine variant waning immunity [DOI] 10.3390/v14061315 PMC 바로가기 [Article Type] Article
Chronic lung lesions in COVID-19 survivors: predictive clinical modelCOVID-19 생존자의 만성 폐 병변: 예측 임상 모델Article Published on 2022-06-132022-09-11 Journal: BMJ Open [Category] COVID19(2023년), SARS, 치료기술, [키워드] Abnormalities abnormality architectural distortion automated Brazil bronchiectasis build Chest Chest CT chest imaging chest X-ray chronic Complete country COVID-19 COVID-19 infection CXR detect Dyspnoea e parameters Early detection eligible forced vital capacity FVC Ground-glass opacities hospital hospital discharge hospitalised joint lung lung lesion lung lesions Medical Research Council mMRC outcome oximetry parameter parenchymal Patient Predictive prospective cohort study protocol Pulmonary function pulmonary involvement pulmonary lesion pulmonary lesions respiratory medicine (see thoracic medicine) reticulation RT-PCR SARS-COV-2 infection SARS-CoV-2-infected patient sensitivity specificity spirometry survivor Thoracic traction bronchiectasis vital capacity were used [DOI] 10.1136/bmjopen-2021-059110 PMC 바로가기 [Article Type] Article